[A nomogram for predicting lymph node metastasis in early gastric cancer]
1Department of General Surgery & Instituteof General Surgery, Chinese PLA General Hospital First Medical Center, Beijing 100853, China School of Medicine, Nankai University, Tianjin 300071, China.
Summary
Female sex, ulcer-type tumors, vascular invasion, lymphatic cancer thrombus, tumor length ≥3 cm, deeper mucosal invasion, and poor differentiation are key risk factors for lymph node metastasis in early gastric cancer. A nomogram model aids in predicting this metastasis.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Pathology
Background:
- Early gastric cancer (EGC) risk stratification is crucial for treatment decisions.
- Lymph node metastasis (LNM) is a primary determinant of prognosis in EGC.
- Accurate prediction of LNM aids in personalized treatment strategies.
Purpose of the Study:
- To identify independent risk factors for lymph node metastasis (LNM) in early gastric cancer (EGC).
- To develop and validate a nomogram prediction model for LNM in EGC.
Main Methods:
- Retrospective cohort study including 1633 patients (training set) and 239 patients (external validation set).
- Univariate and multivariate logistic regression analyses to identify risk factors.
- Nomogram construction and validation using receiver operating characteristic (ROC) curves and calibration plots.
Main Results:
- Multivariate analysis identified female sex, ulcer-type tumor morphology, vascular invasion, lymphatic cancer thrombus, tumor length ≥3 cm, deeper mucosal invasion, and poor differentiation as independent risk factors for LNM.
- The nomogram demonstrated good predictive performance with an area under the curve (AUC) of 0.818 in the training set and 0.765 in the validation set.
Conclusions:
- Several clinicopathological factors are significantly associated with LNM in EGC.
- The developed nomogram model offers valuable diagnostic utility for predicting LNM in EGC.
- This model can assist clinicians in selecting appropriate treatment strategies for EGC patients.


